New COVID-19 Cases Back to 400s... One Additional Death After Vaccination (Update)

429 Local Cases, 18 Imported Cases
26,538 New First Dose Vaccinations...Total 820,000

Post-Vaccination Adverse Reactions: 4 Suspected Anaphylaxis Cases, 1 Death

On the 22nd, citizens are waiting to undergo specimen testing at the temporary COVID-19 screening clinic set up at Seoul Station Plaza. Photo by Moon Honam munonam@

[Asia Economy Reporter Kim Ji-hee] On the 30th, the number of new domestic COVID-19 cases recorded 447. After being in the 300s the previous day, the count rose back to the 400s within a day.

The Central Disease Control Headquarters (CDCH) announced that as of midnight on the day, 447 new domestic COVID-19 cases were confirmed, bringing the cumulative total to 102,582. Regarding the infection routes, 429 cases were locally transmitted, and 18 were imported cases.

By region, 140 cases were confirmed in Seoul and 112 in Gyeonggi. In Incheon, 18 people tested positive for COVID-19, bringing the total cases in the metropolitan area to 270. In non-metropolitan areas, Busan reported 42 cases, still a high number, followed by Chungbuk with 27, Jeonbuk 25, Gyeongnam 15, Gangwon 13, Daegu 12, Daejeon 11, Chungnam and Gyeongbuk each 4, Ulsan 3, Sejong 2, and Gwangju 1. No new cases were reported in Jeonnam and Jeju.

The cumulative number of COVID-19 deaths increased by 3 from the previous day, reaching 1,729. The number of critically ill patients increased by 2 to 102. The number of patients who recovered and were released from isolation increased by 439 to 94,563.

On the day, the number of suspected case tests was 47,669, and the number of tests at temporary screening clinics in the metropolitan area was 37,161, bringing the total number of tests to over 80,000. At the metropolitan area temporary screening clinics, 56 confirmed cases were identified.

Meanwhile, the COVID-19 Vaccination Response Promotion Team reported that as of midnight, 26,538 people received their first dose, bringing the total number of first-dose recipients to 822,448. The number of new second-dose vaccinations was 919, with a cumulative total of 6,151. So far, 761,771 people have received the AstraZeneca vaccine, and 60,677 have received the Pfizer vaccine.

The number of suspected adverse reactions reported after COVID-19 vaccination increased by 138 from the previous day, totaling 10,485. Among the newly reported adverse reactions, there were 4 suspected anaphylaxis cases and 1 death. The rest were mild symptoms such as muscle pain and headache.

This content was produced with the assistance of AI translation services.